Doctor reviewing digital health data on tablet
Advisory & Consulting
1 min. readAdvisory & Consulting

DiGA Approval: What International Providers Need to Know When Entering the German Market

The German DiGA market offers enormous opportunities in a complex regulatory environment. The BfArM review process, the high requirements for clinical evidence, the reimbursement pathways via statutory and private health insurance: those who do not understand these mechanisms lose valuable time and resources. Particularly for providers from inside and outside Europe, there are invisible hurdles that make a well-founded market entry strategy indispensable.

Share:

Understanding the DiGA Fast-Track Review Process

The Federal Institute for Drugs and Medical Devices (BfArM) reviews DiGA applications in a two-stage process: after provisional listing, the manufacturer must provide clinical evidence to be permanently included in the DiGA directory. The requirements for data protection, information security and interoperability are non-negotiable and must already be fully met at the time of application.

Reimbursement by Statutory and Private Health Insurance

DiGA approval means automatic reimbursement eligibility by statutory health insurance, which is very attractive in the German market. The reimbursement amount is set by the manufacturer in the first year, then negotiated with the GKV-Spitzenverband. For all providers, the key point is that the price must be set such that the high costs of clinical studies and ongoing regulatory compliance yield a return, while remaining competitive.

Specific Hurdles for International Providers

In addition to CE marking under MDR and GDPR compliance, international providers must understand the particularities of the German healthcare system: the role of the Kassenärztliche Vereinigungen, the importance of specialist society guidelines, realistic expectations of doctor-patient communication, and ultimately the physician’s motivation to prescribe. A market entry that does not comprehensively and optimally account for these factors can fail regardless of the quality of the product.

Recommendation

Start building regulatory expertise from the early project phase. Envision the price negotiation and plan backwards. An experienced implementation partner with deep DiGA expertise can make the difference between a successful market entry and a costly failure.

PS

Dr. Patrik Scholler

Consultant for Digital Health, Life Sciences and Managed Delivery

More about me
Share:

Do you have a concrete project?

Talk to us about your project, no obligation, at eye level.

Schedule a conversation

More Insights